Deregulation of enhancer states has emerged as a critical step in the activation and maintenance of aberrant transcriptional programs in T-ALL,36,38,62,63 which provides rationale for targeting chromatin regulators associated with enhancers as a viable anti-cancer strategy, such as pharmacological inhibition of BET proteins. The gene discussed is DNER; the disease is cancer.